New drug combo tested to shrink tough pancreatic tumors for surgery
NCT ID NCT05908747
Summary
This study is testing whether adding a drug called surufatinib to standard chemotherapy helps people with pancreatic cancer that is difficult to remove with surgery. The goal is to shrink the tumors first to make surgery more successful and improve long-term outcomes. It will involve about 29 participants and closely monitor safety and how well the treatment works.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300000, China
Conditions
Explore the condition pages connected to this study.